Bayer's Innovator In Chief: Kemal Malik
This article was originally published in Scrip
Dr Kemal Malik likes change. The new and novel, which coincidentally is also Malik's definition of innovation, are the momentum that keeps his role as head of innovation at Bayer AG interesting and fun.
You may also be interested in...
Scrip spoke with several executives and attended multiple panel discussions in San Francisco during the first full day of BIO's annual international gathering. Drug pricing and enabling innovation emerged as key themes.
Biodiversity footprinting may still be a new concept for pharmaceutical companies, but they need to put a clear supply chain strategy in place now, particularly as the COP 15 conference in December is expected to discuss mandatory reporting of biodiversity risks, says Luka Brown.
United Health's pharmacy benefit manager outlined plans for early inclusion of up to three biosimilar versions of adalimumab on its formularies in 2023, at parity to the brand.